As of Dec 15
| -0.02 / -1.16%|
The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 7.00. The median estimate represents a +309.36% increase from the last price of 1.71.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.